[CCoE Notice] Can you ID Neurotoxicity? 

Tue Dec 7 10:34:06 CST 2021

Please contact us at egrrsrch at uh.edu<mailto:egrrsrch at uh.edu>, if you require any assistance or plan on applying to the below opportunity.

Thank you.

Calling innovators aiming to optimize patient care for immunotherapies within the hematologic malignancy space.

Calling innovators aiming to optimize patient care for immunotherapies within the hematologic malignancy space

Images missing? View this email as a web page here<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR_h5nKwhV3Zsc37CgHk-W3m_CV41Mb7FpVBk5SN88YY0vVXbkTL60FLQzW3KBX347YLwsjW3PJrbX5J9C4HW8kHgYR2V3G7RW7wkCfx86bpbXVQzJV07K0BpHW13Cq7K12y4wKW5jQgRD4-4WHSW9fHts986Fc83W6vr9K-8LVRKsW7X27SW6BfZRRW2Ys1nj3kRFhkN15GgK2pKTqmW2LW6JZ8v9prCW3bXRXL6B9nCBW5GQ86c54ZlWFW8Yv3Mr5HD6g7W3_1ZM_5rW2TqW4WTMWz8lhKqlW2qYcY83XW3c8W1wxMZd3w7pmNW1Ls25C2v1K-LV8M_3M5bPD1qN44KhlcZSH_jW3qcGll2kJ6YDN870FD679Rh7W3G3Ykl4-gpNSW4qKrY28cD5dfW3xM6Q07qrbNQW5hz6wn106l87W24jC2g5lDSdWW4JKt7X8bny4BW6b2fg16wp9VJW84BF-m6jvd7zW9gdKn15gBzZ-W8WnjDx50mlDJW8cn9932Pl6VsN4PHhtWtZ8Ms3kqw1__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1p-vOHbbg$>.

[Johnson & Johnson Innovation | JLABS]<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR_B3q90pV1-WJV7CgYCZW1ww28B1C-kx1W8r_69s6qqz48W3y9g9Y5VXqYVW2Kq5Yn9hF8h3W4rlT3G4HwLF6W6YnWf491TKQGN5wmXrRx3GMsVXvysV6gLjWPW5THBR67vCF3mW8XKkX88mHygBW69f_n73KpW6MW5GXLwg53gF1KW99mwkm6xxs89W3q_jhH8b1QHRW4s2b2j3_PzqxW9bXy956py-S6W1TthZm12jr-1W77YZZF83CB1JW1Z52pp4zlrN_W6LR9Wn6XTHtLW5C4TxS6Z1CBMW2sSR2P7BJg46W6625D44YBwlVW5PTj8h1XQ98jW6WYX9R5xby7qW7Z7-1y2B8bVk3ldM1__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1r5vUHTBg$>

QUICKFIRE CHALLENGE BRIEF

[neurotoxicity]<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR-p5nKvpV3Zsc37CgFRMW4Kms_M22WMQKW2m5k4w48Bd2TW3vGkzk3ng67zW6SxQrP1SGLpdVfxmL91bKl2SN5dfS1cyRDL6W4JGRCR6H3NLBW83rtY94prY3gVNVhNP48g6TmN7stG2Z8nxsZV-bhry76KlRYW2KWTGt3T6zXXW5R01fv7J1yczN8-BG6VNpLsxN2CyCpKdnQwyW7fHSmK61hSvrW5Kj_k03NTJ_mW2h-9Cx9jCdQxW4SBJbp1xdyX6W4dBLg71Bs4CnW4mRRNn5TDSTlW4M9p1w3_m-bHW7ZmKX-2G9WzFW5fkpYt3VPKy1V1gCz06vxQ2RW2fghcd7qz5zlW16tjbL5cwzc-W5ZyX4B7tKgLzVJfHBS7n_7kvVrxSxy1Q-jLzW78Xqc462nCBMW2RjW238Ynb_hW3TXT9c81Qj_HW2T4G8L2-bRVN38Hl1__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1pZq4FgBQ$>

Submission deadline: March 18, 2022

Improving Detection of Neurotoxicity in Immunotherapies

[Enter the challenge]<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR-57SWmBV5X_Kf7CgD71W4lK9S22QzCpTW5-FXy97_hLCZW7Y0xhG97hwfnW4-FdNS57Hc9zW8-JDhP9jn_GbW1G-gkS4rkg38W2qHwZz2hsFX_W1wz1db4sJMgMN2gFPFnHRkc7W41X59y4NWZb-W6znmW64jbcxHW6sm_M66xrzHFW5m6b9x6TfH6yW5zD_5Z69qq7rW5FhkTq6FG07yW7kBkd12tQHmsW6NsGsx2jYHXlW1RSGQt5Q-TmrW3K0lbj4x30Z9W2dDbDY3bcPD_W3T5nkd1npRD1W6MLFc35YTpYYW5RhGBQ8hD-VrW1hfXJV965ntMN3Lh5wCldRrnW82P3Fr98R3K0VH8gNx1cKwPfW7zJz1q7rbTl1W3ypybb5dY4kfW5jbyLG1Zrcq3W3YX9DW7c00YBW31kQLs32nCnNW1-hJn-1tvV3ZW93Hcq61MSR4ZW5z0LZV72WzhLW5HGTYC6cBpZWW3rHzL11NCy8tW3Mx5tG4kXWy5W3flbrJ70yFY3W7WjtXR7wF9HwN4QChcdYgv7_W6rt4Ks5V7Dc4N9lL6hmLqF1ZW1D2k8W16l4YyW3b0fF880kXzGW5-6S6J4lJSlPW7pK84L1glWvFW9kv2Xz7yDd0l38g21__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1o5lnToEw$>

Dear Shilpa,

There are new immunotherapy cancer treatments<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR_V3q90JV1-WJV7Cg-dGW6x-8Jp7rxV0SW1vss8F30gs-3N62yfsfxLXtzW6pyymR7b2lw1W42lf8l8bFBkHW8NCgn31vYNMjW33NgQq3f3QP7VKR9Wg70qV31VJ-CWQ7Vt0vsVhdrkC3sY_XCW906mCM8jKmqnW6Hq5Fj8j9t6hW5Vp9L_4-XklhW6k98Zw38ls9KN2QBtWY7mF5jW2FCsf56yf8LbW8V5wV921DLNJW4VgJNZ2Z2f8sW52L3QQ8nnKF8W909_9B8j24k4W6YYpQt6XgYPyF2t4Jc1-ZrJW1zZkCR2WpBYcW1XP3912NMVB-Mg3_rYn0S22W6z3fgg5CLkH6W8lnDCm981QJdW1GvPlB1c-rxb31D01__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1o1K2KPGQ$> available for hematologic malignancies, such as T-cell based immunotherapies and chimeric antigen receptor T-cell (CAR-T) therapies. However, some patients experience neurotoxicity<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR_h3q905V1-WJV7CgVPRW1mbdJT70K24DW2hwp8t37rsNnW24CBHG1NFQBvW8N9wXS2Zcz8RW6Y7gsn4t0crJW6bNfs67_c8wPW2nPf5P745XGjW1PR-c34W_3nsW45TYCY5Cn_tBW96KkpQ40mHNDVlzd6Z3Wt5NwW18q7by4fbqr7W77W7J969kks3W5gHhcd8ZWmrBVkk9X825fYLjN8pzb2L93SP8W1gf5355fYbXjN9bzVvmD2rstW88cB-n7SfCtZN54mLLRm7fg6W5nxYdP2RygZ-W3XP4MZ1jGMV-W2HjPbf2Ln6x9W4ZpDQQ3h9_Yp21C1__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1on49FTDw$> as a result of treatment.

Although sometimes severe, neurotoxicity is primarily reversible and can be detected through specialized patient monitoring and care.

Johnson & Johnson Innovation is proud to launch the I.D. Neurotoxicity in Immunotherapies QuickFire Challenge.

Challenge rewards1

[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hubfs/3988599/Icons/JNJ_Icon_Partnership_White.png__;!!LkSTlj0I!C0Ccl5dM7XEnzdD6K8BiUIY68jIvJOCciXoC2-7iC-tneSZts4w2GR-1oliVx2S-fq4d3ZsQb9TZJQrYp9BcOsBlx-0$ ]

Expert mentoring2

[https://urldefense.com/v3/__https://hs-3988599.f.hubspotemail.net/hubfs/3988599/Icons/JNJ_Icon_Beaker_White.png__;!!LkSTlj0I!C0Ccl5dM7XEnzdD6K8BiUIY68jIvJOCciXoC2-7iC-tneSZts4w2GR-1oliVx2S-fq4d3ZsQb9TZJQrYp9BciNw8QKM$ ]

Access to the JLABS ecosystem3

[JNJ_Icon_USD_White_RGB]

Grant funding up to increments of $200,000, $125,000, and $75,000

Areas of Interest

Visionaries are invited to submit methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling early detection of neurotoxic events. Of particular interest are technologies aiming to identify clinical manifestations to predict acute toxicities, including movement and neurocognitive disorders.

[Enter the challenge]<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR-57SWmBV5X_Kf7CgWDpW8H5t-l5dXvvWW18WcrB5vllTGW1jWl_t8CDpn_W7Vf1Rw8Kj7FgW6_grV85-61HqW63Lj3R6GHt67W8f3Lpq7ybq77V5M92B1TzvjkW1jKR271qlC1RW2bmXXQ5Z37FRW45C69L3Y6Ml5W5qCYDN6l3Y9TW7J_mmy3_FNZwW3k3Cz46XFh-nW58cths95k4kfW6Fk-9z3KJrhJVHrp4y5F6LPYW4tFJNH3rrh8PW3lL5kh34QCBqN8Bg_vR_06wCW8XF2KW5Xn6MVW3XhpCl2Z7bgnW6nRWCx1BPgV0N8QWhrjRkM11W4kHcjc80FwxcW2Hy7hm81qZlLW58HW5G3xPFkpV3bkn_6nTQtJW8V3nR02n8FdXW6KY94-4TfShrN6kG1B9BH9qtW7P3HDr67LDqhW90-Msz2kj32PW5YF11j3sq_MlW7C6MMm5ZwWrFW4GJJV11kTsbFW5GJRSb16LZMCW24dgWr6lwQJzVcBdsj5TSlScW4-gCKp6MYxVVW7l8R4l4Vt738W3Xz3-G5LRMHwW1XwzH844r0lPW66b-6k4pB43NW6gXPSh61ZDnbVctTny3cBkDFVQR38r85C6jWVx89_D1q2qWf36G-1__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1okLLUXGw$>

Partners

[janssen_jnj]

1. Subject to the execution of the necessary documentation and (award) agreements.
2. Mentorship from experts at the Johnson & Johnson Family of Companies
3. Access to the global Johnson & Johnson Innovation - JLABS ecosystem

© Johnson & Johnson Innovation 2021.
1 Johnson & Johnson Plaza | New Brunswick, NJ  08901 | USA
You received this email because you are subscribed to QuickFire Challenges Brief from Johnson & Johnson Innovation.
Update your profile<https://urldefense.com/v3/__https:/ctkRZ04.na1.hubspotlinks.com/Btc/ZR*113/ctkRZ04/VWlZ638-3HYDW8fpVV54xFNGqW8rPchQ4BPvvvN1WCR_B3q90pV1-WJV7CgGFvW8MsrX96QQGTPVsmX8z176tgVN3K5L-KSn8LTVrQdNW6GxzdPW3_0nts8xBcVwW4k5pPW4kyZLYN4JPSYC9BvVrW7t5zdx8zn2sKW4PQSch70Lk2NW8hlBF468vxjBW6ZP5V24ykczKW3V6SRX6LJyLdW2Dc0nC2F_X8RW79cPQ97yZxH3W2Bnc-K4V2twZW8934fj5_mrPtW6mxT997B-jsBW7LWpHP20bcj2VM_HPX3hHWDVW7y3ymw7wZcR4W6ZrRxJ4ssPL2N6BZDDb_CyDgW4GngXG2RQ5cTW3C6f-z243nc9W85FWT58PzKX2W8dYFDY1x_VP13hF41__;Kw!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1rMj2OwgA$> to choose the types of emails you receive, or unsubscribe from future emails<https://urldefense.com/v3/__https:/hs-3988599.s.hubspotemail.net/hs/manage-preferences/unsubscribe?d=VnbTNN6MXH38VCsNKB3R5JYDW3JH5dN3Qz74WW4h26H75DV1tyVmWFfX7ZmsHVN8N4wyG25zWwW7GLPy06MnkBZVWMl4C6h3RcsMXk_7Qbw2cVW83K_HX94qD-bW3KhjzS3QLdds37-M2&v=3&utm_campaign=QFC*20Detection*20of*20Neurotoxicity&utm_source=hs_email&utm_medium=email&utm_content=190352130&_hsenc=p2ANqtz-9h4t0bXrfr90DSF9AeHId2tSfYiD0S4YK1ZPJYHB_ycU9OhUlvqfUkSbVLj9pU5dPsWRZRYX_fHJIgsd1ZOW42ByrY1Q&_hsmi=191848419__;JSUl!!LkSTlj0I!Ed0c1x7Im7dPzsx4-Z8EVi4rcuIuwNcs_ZeT-73uoXus_dwz5Zk2jqJ7COHgY1eYNxvaCKKdK1pW-q1iUA$>

This email is from Johnson & Johnson Innovation and represents a selection of activities from across our Innovation Centers, JLABS, and JJDC, as well as Johnson & Johnson Family of Companies. The information in this email is for informational purposes only. The information is either proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies ("JJI and Johnson & Johnson") or is provided by or proprietary to third parties. In case of third party information, please note that only those third parties that provided or own this information are responsible for it. By providing this information, JJI and Johnson & Johnson do not endorse these third parties or any of the information provided in this email. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of JJI or Johnson & Johnson. JJI and Johnson & Johnson are not responsible or liable for any actions you do or do not take in relation to this information and are not responsible for any use of this information by you. By providing the information in this email, JJI and Johnson & Johnson do not make any representations, warranties, or assurances, express or implied, as to the content or the information presented in this email and is not responsible for any use by or alterations of this information by you. JJI and Johnson & Johnson hereby expressly disclaim any and all guarantees, representations, warranties, or assurances and assumes no responsibility or liability, direct or indirect in relation to the information in this email.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://Bug.EGR.UH.EDU/pipermail/engi-dist/attachments/20211207/e4dac2c1/attachment-0001.html 